XML 70 R20.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders' equity
9 Months Ended
Sep. 30, 2024
Stockholders' Equity Note [Abstract]  
Stockholders' equity STOCKHOLDERS’ EQUITYCommon equity transactions
In February 2024, we entered into a new ATM common stock offering program that allows us to sell up to an aggregate of
$1.5 billion of our common stock
During the three months ended June 30, 2024, we entered into new forward equity sales agreements aggregating $28 million
to sell 230 thousand shares of common stock under our ATM program at an average price of $122.32 (before underwriting discounts).
As of September 30, 2024, none of these agreements were settled.
During the three months ended September 30, 2024, we had no activity under our ATM program. As of September 30, 2024,
the remaining aggregate amount available under our ATM program for future sales of common stock was $1.47 billion.
Dividends
During the three months ended March 31, 2024, we declared cash dividends on our common stock aggregating $222.1 million,
or $1.27 per share. In April 2024, we paid the cash dividends on our common stock declared for the three months ended March 31,
2024.
During the three months ended June 30, 2024, we declared cash dividends on our common stock aggregating $227.4 million,
or $1.30 per share. In July 2024, we paid the cash dividends on our common stock declared for the three months ended June 30, 2024.
During the three months ended September 30, 2024, we declared cash dividends on our common stock aggregating
$227.2 million, or $1.30 per share. In October 2024, we paid the cash dividends on our common stock declared for the three months
ended September 30, 2024.
Accumulated other comprehensive loss
The change in accumulated other comprehensive loss attributable to Alexandria Real Estate Equities, Inc.’s stockholders
during the nine months ended September 30, 2024 was entirely due to net unrealized losses of $6.6 million on foreign currency
translation related to our operations primarily in Canada.
Common stock, preferred stock, and excess stock authorizations
Our charter authorizes the issuance of 400.0 million shares of common stock, of which 172.2 million shares were issued and
outstanding as of September 30, 2024. Our charter also authorizes the issuance of up to 100.0 million shares of preferred stock, none
of which were issued and outstanding as of September 30, 2024. In addition, 200.0 million shares of “excess stock” (as defined in our
charter) are authorized, none of which were issued and outstanding as of September 30, 2024.